Prostate Cancer - Results from #2300

The impact of race on survival in metastatic prostate cancer: a systematic literature review. August 21, 2023

Prostagram MRI in a Screening Population: PI-RADS or Likert? August 21, 2023

Racial/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort study. August 21, 2023

Genomic and Phenotypic Biomarkers for Precision Medicine Guidance in Advanced Prostate Cancer. August 21, 2023

Do Bone Scans Overstage Disease Compared with PSMA PET at Initial Staging? An International Multicenter Retrospective Study with Masked Independent Readers. August 21, 2023

Survival of veterans treated with enzalutamide and abiraterone for metastatic castrate resistant prostate cancer based on comorbid diseases. August 21, 2023

Frailty and survival among veterans treated with abiraterone or enzalutamide for metastatic castration-resistant prostate cancer. August 21, 2023

Plain Language Summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide? August 18, 2023

Prospective clinical sequencing of 1016 Chinese prostate cancer patients: uncovering genomic characterization and race disparity. August 18, 2023

18F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure: A matched cohort study. August 18, 2023

SPOP mutations target STING1 signaling in prostate cancer and create therapeutic vulnerabilities to PARP inhibitor-induced growth suppression. August 18, 2023

Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging-Targeted Biopsy: Transforming Prostate Cancer Diagnosis. August 18, 2023

Club-like cells in proliferative inflammatory atrophy of the prostate. August 18, 2023

ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression. August 18, 2023

ASCL1 is activated downstream of the ROR2/CREB signaling pathway to support lineage plasticity in prostate cancer. August 18, 2023

PLEKHS1 drives PI3Ks and remodels pathway homeostasis in PTEN-null prostate. August 18, 2023

Hospital encounters and associated costs of prostate evaluation for clinically important disease MRI vs. standard evaluation procedures (PRECISE) study from a provincial-payer perspective. August 17, 2023

Randomized Phase II Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in the Treatment of Metastatic Castration-Resistant Prostate Cancer. August 17, 2023

An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading. August 17, 2023

The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy. August 17, 2023

Page 116 of 1439